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Association analysis between (AAT)n repeats in the cannabinoid receptor 1(CNR1) gene and smooth pursuit eye movement(SPEM) abnormality in Korean patients with schizophrenia. Abstract Objective: According to previous studies, the cannabinoid receptor 1 (CNR1) gene could be an important candidate gene for schizophrenia which is located on chromosome 6q14-q15. The association between CNR1 polymorphisms and schizophrenia is actively being investigated, and some studies have linked the AAT-trinucleotide repeats in CNR1 gene with the risk of schizophrenia. Meanwhile, smooth pursuit eye movement(SPEM) has been regarded as one of the most consistent endophenotype of schizophrenia.
In this study, we investigated the association between the AAT-trinucleotide repeats in CNR1 gene and smooth pursuit eye movement abnormality in Korean patients with schizophrenia. Methods: We measured SPEM function in 187 Korean patients with schizophrenia (84 male, 83 female) and they were divided according to SPEM function into two groups, good and poor SPEM function groups. We also investigated allele frequencies of AAT-repeat polymorphisms on CNR1 gene in each group. A logistic regression analysis was performed to find the association between SPEM abnormality and AAT-trinucleotide repeats in each group. Results: The natural logarithm value of signal/noise ration(Ln S/N ratio) of good SPEM function group was 4.34 ± 0.29 and that of poor SPEM function group was 3.21 ± 0.70.
In total, 7 types of trinucleotide repeats were identified, each containing 7, 10, 11, 12, 13, 14, and 15 repeats, respectively. (AAT) 13 allele was most frequently observed, with a frequency of 30.5%. The frequencies of the other repeat alleles (in the decreasing order) were as follows: (AAT) 13 30.5%, (AAT) 14 24.3%, (AAT) 12 19.8%, and (AAT) 7 11.1%.
However, no significant associations were found between the number of AAT-repeat polymorphisms of the CNR1 gene and SPEM function. Conclusions: No significant associations were found between AAT-trinucleotide polymorphisms and SPEM abnormality in Korean patients with schizophrenia. Abstract Schizophrenia is a devastating mental disorder with high heritability estimate up to 80%. Secretory pathway of peptide hormones and neuropeptides in brain is regulated by chromogranin proteins. Chromogranin B (CHGB), a member of chromogranin family gene, is proposed as one of the candidate genes for the risk of schizophrenia. In a genome wide association study performed in a Japanese population, genetic variant (microsatellite: D20S95) near CHGB could be a potential genetic marker for the schizophrenia development.
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Genetic variants in
In the current study, 15 SNPs of CHGB were genotyped in 310 schizophrenia patients and 604 healthy controls to investigate the association with the schizophrenia susceptibility. Statistical analysis has revealed that four genetic variants (rs446659, rs6133278 (D145N), rs910122 (R178Q), rs2821) were associated with the reduced risk of schizophrenia . In the subgroup analysis, five genetic variants (rs236141, rs446659, rs6085323, rs910122 (D178Q), rs2821) and a haplotype (ht3) showed more protective effect on the schizophrenia in male subjects (OR=0.52-0.74, p=0.002-0.05), but not in female subjects.
Our results demonstrated that genetic variants in CHGB showed gender-specific effect to the reduced risk of schizophrenia, which could be a useful preliminary result for further study.
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Aberrant cortico-cerebellar connectivity of the default mode network in individuals at ultra-high risk for psychosis: a resting-state fMRI study 
